Skip to main content
. 2021 Mar 8;16(3):e0248010. doi: 10.1371/journal.pone.0248010

Table 1. Results, normal distributed data represented by the mean ± standard deviation, not normal distributed data represented by the median (lower quartile; upper quartile).

Time period Time period p- value
2017–2019 2020
March 20th–May 7th 2017, March 19th–May 6th 2018, March 18th–May 5th 2019 March 16th—May 3rd
General Data
Patient number 22.3 (± 1.2) 15
2017: 21
2018: 23
2019: 23
Age (years) 58.7 ± 9.9 63.1 ± 13.0 0.144
Gender Male: 13.3 ±5.5 (60%) Male: 10 (67%) 0.617
Female: 9 ±4.6 (40%) Female: 5 (33%)
Lens status (prior to surgery) Phakic: 13.7 ±1.5 (61.4%) Phakic: 8 (53%) 0.318
Pseudophakic: 8.3 ±2.5 (37.2%) Pseudophakic: 6 (40%)
Aphakic: 0.3 ±0.6 (1.4%) Aphakic: 0
Secondary IOL: 0 Secondary IOL: 1 (7%)
Retinal Detachment morphology
Involvement of quadrants (amount) I: 5.7 ±1.5 (25.6%) I: 2 (13.3%) 0.650
II: 10.3 ±3.1 (46.2%) II: 8 (53.3%)
III: 4 ±1.7 (17.9%) III: 4 (26.7%)
IV: 2.3 ±1.5 (10.3%) IV: 1 (7.7%)
Holes (number) 2.87 ± 1.74 3.29 ± 2.16 0.434
Proliferative vitreoretinopathy status None: 11.3 ±2.3 (51%) None: 4 (27%) 0.191
Grade A: 2.3 ±1.2 (10%) Grade A: 4 (27%)
Grade B: 6.7 ±2.9 (30%) Grade B: 5 (33%)
Grade C: 2 ±1.7 (9%) Grade C: 2 (13%)
Macula status Macula ON: 7.7 ±1.2 (34%) Macula ON: 5 (33%) 0.597
Macula OFF: 14.7 ±1.2 (66%) Macula OFF: 10 (67%)
Off clinic ophthalmologist consultation Yes: 12 ±2 (52%) Yes: 10 (67%) 0.395
No: 10.7 ±2.1 (48%) No: 5 (33%)
Delays
        Patient delay Median: 4.0 (1.0; 8.0) Median: 6.0 (1.0; 9.0) 0.484
        Diagnosis—first clinic contact (referral/doctors delay) (days) Median: 0 (0; 0) Median: 0 (0; 0) 0.992
        First presentation -Surgery (Surgery delay) (days) Median: 1.0 (1.0; 2.0) Median: 1.0 (1.0; 1.0) 0.852
Macula-ON 1.0 (1.0; 1.0) Macula-ON 1.0 (1.0; 1.0)
Macula-OFF (1.0; 2.0) Macula-OFF (1.0; 1.0)
        First symptoms -Surgery (total delay) (days) 9.42 ± 13.14 8.6 ± 8.3 0.740
Median: 5 (3.0; 8.0) Median: 7 (3.0; 12.0)
SURGERY Details
Surgery duration (minutes) 64.8 ± 36.8 71.4 ± 25.2 0.514
Surgery type Vitrectomy + SF6: 9 ± 3.5 (40%) Vitrectomy + SF6: 6 (40%) 0.614
V.C2F6: 8.6667 ± 1.5 (39%) Vitrectomy + C2F6: 4 (27%)
V. + C3F8: 2.6667± 2.1 (12%) Vitrectomy + C3F8: 4 (27%)
V. + Silicon oil: 1.3 ± 0.6 (6%) Vitrectomy + Silicon oil: 1 (7%)
Buckling Surgery: 0.6667 ± 1.2 (3%) Buckling Surgery: 0 (0%)
Combined cataract surgery Yes: 3 ± 1 (14%) Yes: 3 (20%) 0.992
No: 19.3 ± 2.5 (87%) No: 12 (80%)
Single surgery success Yes: 19.3 ± 2.1 (85%) Yes: 11 (73%) 0.275
No: 3.3 ± 1.2 (15%) No: 4 (27%)